783292-37-5 (阿巴卡韦EP杂质D,Abacavir EP Impurity D)

阿巴卡韦EP杂质D;

Abacavir EP Impurity D;Abacavir, trans-;ABACAVIR SULFATE IMPURITY D [EP IMPURITY];ABACAVIR, (1R,4R)-;2-Cyclopentene-1-methanol, 4-(2-amino-6-(cyclopropylamino)-9H-purin-9-yl)-, (1R,4R)-;TRANS-ABACAVIR R,R-;4-(2-AMINO-6-(CYCLOPROPYLAMINO)-9H-PURIN-9-YL)CYCLOPENT-2-ENYL) METHANOL, (1R,4R)-TRANS-;TRANS-ABACAVIR, (+/-)-;(1R,?4R)?-?rel-4-?[2-Amino-?6-?(cyclopropylamino)?-?9H-?purin-?9-?yl]?-?2-?cyclopentene-?1-?methanol;(1R,4R)-rel-4-[2-Amino-6-(cyclopropylamino)-9H-purin-9-yl]-2-cyclopentene-1-methanol; 2-Cyclopentene-1-methanol, 4-[2-amino-6-(cyclopropylamino)-9H-purin-9-yl]-, (1R,4R)-rel-; rel-(1R,4R)-4-[2-Amino-6-(cyclopropylamino)-9H-purin-9-yl]-2-cyclopentene-1-methanol; trans-(+/-)-Abacavir; (+/-)-trans-Abacavir;ABACAVIR, TRANS-, (+/-)-;0903H757IU;UNII-0903H757IU;DTXSID90228998;1443421-67-7;((1R,4R)-4-(2-AMINO-6-(CYCLOPROPYLAMINO)-9H-PURIN-9-YL)CYCLOPENT-2-ENYL)METHANOL;TRANS-ABACAVIR [USP IMPURITY];((1R,4R)-4-(2-Amino-6-(cyclopropylamino)-9H-purin-9-yl)-cyclopent-2-enyl)methanol;6BVN3YCO99;Abacavir sulfate impurity D [WHO-IP];trans-Abacavir;[(1R,4R)-4-[2-AMINO-6-(CYCLOPROPYLAMINO)PURIN-9-YL]CYCLOPENT-2-EN-1-YL]METHANOL;783292-37-5;UNII-6BVN3YCO99;(1R,4R)-trans-4-(2-Amino-6-(cyclopropylamino)-9H-purin-9-yl)cyclopent-2-enyl) methanol;2-CYCLOPENTENE-1-METHANOL, 4-(2-AMINO-6-(CYCLOPROPYLAMINO)-9H-PURIN-9-YL)-, (1R,4R)-REL-;SCHEMBL1287471;

MCGSCOLBFJQGHM-WPRPVWTQSA-N

1S/C14H18N6O/c15-14-18-12(17-9-2-3-9)11-13(19-14)20(7-16-11)10-4-1-8(5-10)6-21/h1,4,7-10,21H,2-3,5-6H2,(H3,15,17,18,19)/t8-,10-/m0/s1

OC[C@H]1C=C[C@@H](C1)N1C=NC2C1=NC(N)=NC=2NC1CC1